DPYD Testing

DPYD Testing

468.00 NZD In stock Buy at Merchant

The DPYD Screen test is a genetic test intended to reduce severe toxic and adverse events and improve treatment outcomes for cancer patients receiving fluoropyrimidine drugs.

  • The description claims that the test may be particularly important for cancer patients undergoing therapy with fluoropyrimidine drugs like Fluorouracil (5-FU) and Capecitabine.

How AI sees this product

The more complete this product's details, the more confidently AI assistants can understand and recommend it.

61%